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Cone~us~on: MCE no reflow can discriminate individual patients with the 
high risk of progressive LV remodeling, heart failure and cardiac death from 
those with fav0rahlo outcomes even in the chronic stage el AMI, 
~ Evlden©e for Advoree Interaction Botwean on 
ACE Inhlbltora and Aspirin Following Myocardial 
InfarCtion: The GUSTO.I Trial 
J,G, Paterson, Me, k~uer, J,B, Youn0, S, Sapp, R,M, CaUIf, E,J, Topoi, 
Cleveland Clinic Found~lflOn, Cleveland, OH,/~nd O¢lke Univer~ity, O~rtttlm. 
N¢, USA 
B~ek~round: A~ptrln ha~ been shown to redu0o 10nil-term mort,~llty ~ffer 
a(~ute myocar0ial tnforotion (MI); ~ngiotenstn converting enzyme inhlbitore 
(ACE.I) are al~o ellen used offer MI, There i~ concern thai tlt0~o two 0gents 
may edvor~01y Inforset wllh one another; the Impa~t Of this interaction among 
p_~tl~nls wlfhocd heart latium h~s not boon ~Amfully examined, 
M(}thods: Consecullve MI patients who ro¢otved thromb01ysls at~ part el 
the GUSTO-I trial, who survived o( lea~t 30 d~tys, end who did not d0volop 
heoJrt failure (n ,~ 31,3~8) word studied. Medications el lime of hospital 
discharge were holed, The primary ondpotnt w~ ~ll.o~o~o mortality BI one 
y~ar 
EfO~ttlt~: During follow.~Jp there wore 615 ds~th~ Aspirin was proscribed 
lot I;10% 0l patients, of whom 15% ~leo rsoolved AGE.I, Use of ospinn alone 
w~s associated Will~ reduced mort~tlity (Kaplan.Molor rates 1.7% vt~. 3,7%, 
P • 0,001); I~ewOver, wh0n ACE.I woto concorrontly used, ~sp~r*n was not 
~8~0¢latt~d with reduced morlality (3,5% w, 3,7%, P -- 0,B), After ~dlusting 
lot ~go, gender, treatment, Infarct location, ~nd other ¢onloundors, aspirin 
rem~lns~.l associated with reduced mortality (rslallve risk [RR] 0,43, 05% CI 
0,31,.-0,61, P -. 0,0001); however, AC~.I use haq an adverse Intoraell0n with 
aspirin (adjusted RR for use of both agents a.31, 95% CI 1.17-4,59, P = 
0.02). 
Concll+$ton: Among MI survivors without heart failure, the use OI ACE-I 
after thrombolysi8 may reduce th~ mortality benefit at~sociatod with ~lr~pmn. 
This potentially Important drug Interaction wartant~ further study, 
~28~ Effect of Pro longed Captoprll Versus 
NltrOglycerln Therapy on DlaMoll¢ Dysfunct ion 
After Trensmural Myocardlal Infarction 
M. Balghlth, V, Meade, O.P. Human, B,I, dugdutt UniversttyotAlberta, 
~dmonton. AlOerta, Canada 
BackgrOund: limitation of remodeling with angiolonsin-converting enzyme 
(ACE) inhlbitors after tmnsmur~l acute myocardial infarction (TAMI) is as. 
sociated with improved systolic function, The effects of the ACE inhibitor 
captopril (CL) and nitroglycerin (NTG) on diastolic dysfunction have not been 
compared 
Methods: Quantitahve two-d*mensional echocardiograms and Doppler el 
t 60 patients, who wore randomized (double.blind f~ctorlat design, n = 20/cell) 
48 hours after a first anterior (ATAMi) or intoner (ITAMI) TAMI to placebo, 
CL (6.25-25 mg TID), NTG (buccal t-..3 mg TID; 5 t~ourly with an B-hour 
washout) or NTG + CL for 6 w0oks, wore analyzed for peak early (E) and 
late (A) Ilow velocity, E/A ratio and deceleration time (DT) as well as other 
remodeling parameters at 4 intentals (2 days, 6 weeks, 6 months, 1 year). 
Results: Pement changes over 1 year (mean ± SEM) were: 
Placebo CL NTG NTG + CL 
ATAMI 
E/A ratio tOt9 20~6" 22 ~: 17 28 t: 16 
DT S8 • 13 20 t 9" 39 L 17 36 :L 14 
ITAMI 
~A+alia -6 ~ tS 6 ~ 16 30 t 17 22 * 16 
DT 1 .+ 13 13 ± 7 18 ~ 15 3 ~ 8 
P O 009verSus Placebo {ANOVA) 
COnclusion: Persistent improvement in diastolic function WaS only signifi- 
cant in the ATAMI subgroup receiving Caplopril therapy. 
• Effect Of Beta Blockade on Mortality in Patients 
With Contralndicatlons Post Myocardial 
Infarction 
S.S, Gottlieb, R. McCarter, R. Vogel. University of Maryland School of 
Medicine, Baltimore. MD. USA 
The value el /~-blockers following myocardial infarction (MI) is well docu- 
mented, However, CHF, COPD, left ventricular dysfunction (EF <40). dia- 
betes (DM) & older age are often considered centraindications for their use. 
The impact of tbblockers in pts receiving other medications, such as throm- 
bolytics (Lytics) or ACE inhibitors (ACE) also has not been tested, We used 
CooporaUve Cardiovascular Project data to delineate which patients benefit 
from #-blockers following a MI. 
In 127,370 pts, we compared mortality in pie given (38%) or not given 
(62%) p.bloekors on hospital dlscl}argo, Cox regression meddle were used 
to compare Ihe 3 year survival rates (median 23 months). The m~ls  
accounted for dllfemntlel follow-up and controlled COml~flsons for ~k~mo. 
graphic, physiologic, and comorbld factors. The total mortality (%) ar~ a~ 
lusted risk reduction (RR, %) Is given, 
. . . . . . .  _c~_,  +__~o~ ............ +.~+.:7~ ....... e_ ~::~_0_____°~ .......... uv,~+ A~ 
Mo~l ~?,0 4t.1 4~.~ 4~t,~ ~,7 t~,t ~,9 
Mortality, which ~veragod 9~%, was reduced by 30% in lh~ on pJ~lock_m's, 
/I.blockada was assogi~ted with lower mortality in all ~ul~lroUl~ ot Ip~fieN~, 
Race, age, salt, COPD, ej~llon ft~t;Uon, DM, Lyrics, AC!~, & ol~r a gt~ ~id 
net affeo! RR A hlsten/ol CHF deomased RR, but I~qa~so el the high 
mortality rate, obsolete benefit wi~ similar, 
Them am andoubtodly p~ients In whom #,blecker~ shonld not ~ given, 
However, c~ntrolling for in~li~s 0f di~ea~ severity 8e~ motta!ity n~k, I~t~nl~ 
post MI normally considered to h~ve ~ntrt~in~i~tion~ had l~Itter ~ur~iv~! 
when giwn tl.bl~kem, These data sqggeat th~l #.blocker's hOg!d b@ give1 
t0 pOSt MI pati6nts whenever possible, 
• Different Outcome of  I~t ient~ With SuMalnad 
Monomorphio VantriGuler To©hyc~rdio R~llu!ring 
Cardiovorllon During A©uW M~rt l i I I  
Infarction: Analysis in the GUSTO I Study 
A Natalo, 1". Thompson, E Sga~O.~, G. Wagner, A. I]a~agelata, 
E. Topoi, R. Califf, For the GUSTO investigators, Univ~trsity of K~ntucky 
Lexington, KY: Duke Universi~ Outham, NC, US4 
In the GUSTO I population we analyzed the outcome of patients experiencing 
sustained monomqlphie ventricqlar taehyca~ia (VT) during hospital~zat~. 
Of the 40,895 patients enrolled in the study 1439 (3,5%) I~d sustained 
monomo~hic ventncular tachyca~ia, Age. previous MI. Killip Class, antenor 
MI, and depressed ej~tion hactiun wOru ~l~.,',',',',',',',','~i~t~-'vl with ~ higher ri~k of 
sustained VT. In-hOspital and 30 day mortality rate were higher in the VT 
group (p < 0.001 ). When patients with VT were divided in those who dig (452 
patients) and, did not (983 patients) required electrical cardiovetsion, the 
former group Showed an increased in.hospital mort~dity (35% vs. 11.1%, p < 
0.001). Similarly, the 1 year mortality of 30 day survzvorS was higher in the 
group receiving cardiovorsion (11.3% vs. 5.8%, p = 0.003). However. both the 
cardioversion and no eardioverslon groups had higl'er I year mo~tat,ly ~ate 
than the group without ventncular arrhythmias. In patients with VT tequmng 
cardioversion in-hospital, and t year mortality remained higher than the 
no-arrhythmia group even when analysis was pertotmed ividing the patients 
in those with early (<2 days} and late (>2 days) occunence of sustained 
VT (p -. 0,001). In conclusion among Patients experiencing sustained VT 
during acute MI the need for cardiove.sion identified a subgroup w*th higher 
in-hospital, 1 year mortality regardless of the early or late occurrence Of this 
arrhythmia. 
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I1 -1 I Are Physicians any Better Prepared Than 031 31 
DenUst~ for an Off ice Cardiac Emergency? 
J, P. ornate, MA. Peberdy, J. Campbell, R, Campbell, R. Flank, 
C.J, SchmeiL A. Heffner, P. Kamilakis. Virginia Commonwealth 
University~Medical College of Virginia, Richmond. Virginia, USA 
To determine whether physicians are better prepared than dentists for an 
office cardiac emergency, we randomly surveyed 51 primanj care physi- 
cians (MDs~ and 224 dentists (DDSs) in Richmond, VA. DDSs performed 
conscious sedation (45% vs 4%, p < 0.000001), local (99% vs. 55%, p < 
0.000001) and general anesthesia (8% vs 0%, p < 0.04) more often than 
MDs. More DDSs had oxygen (96% vs. 78%, p < 0.000001) but less often 
had Iv equipment (23% vs 51%, p < 0.00007) than MDs. Although the rate 
of emergencies/100.000 pt visits requiring interventions (CPR, Ambu bag. 
intubation, defibrillation, or drug therapy) was higher in MD vs DDS Offices 
(39% vs 11%, p = 0.006), there were no differences in the % of MD vs 
DDS offices containing an Ambu bag (82% vs 79%, p = 0.59), intubation 
equipment (53% vs 40%, p = 0.10), epinephrine (92% vs 89%, p = 0.49), 
